Document is current
Any future updates will be listed below
-
Authors
Chan, Alfred A.
Sankar, Kamya
Reckamp, Karen L.
Díaz, Begoña
Lee, Delphine J.
-
Funding
Funding for this research was provided by:
Tobacco-Related Disease Research Program (T32IP5106 UC Regents, T32IP5106 UC Regents)
- License Information
-
More Information
Article History
Received: 14 January 2025
Accepted: 14 July 2025
First Online: 13 October 2025
Declarations
:
: Dr. Diaz and Dr. Lee received funding for this research as co-investigators from “T32IP5106 UC Regents, TRDRP Pilot Award” and “T34IR8280 UC Regents, TRDRP Research Award.” Other grants for Dr. Lee within the past 36 months include California Breast Cancer Research Program, UCLA CTSI Core Technology Award, Eastwood Charitable Fund Grant, The Kenneth T. and Eileen L. Norris Foundation, and Department of Defense W81XWH2211029. Dr. Lee serves as BOD for Society for Investigative Dermatology, The Lundquist Research Institute, and American Board of Dermatology. Dr. Reckamp grants or contracts in the past 36 months include Genentech, Blueprint, Daiichi Sankyo, Elevation Oncology, and Janssen. Dr. Reckamp is consulting honoraria to self for Amgen, AstraZeneca, Blueprint, Daiichi Sankyo, Genentech, GlaxoSmithKline, Janssen, Lilly, Mirati, Novartis, Novocure. Dr. Sankar has a career development award from Conquer Cancer - the ASCO Foundation and does presentations for Scripps Oncology. Mr. Chan declare no potential conflict of interest.
